Thus, our study demonstrated an interesting mutual regulation of glutamine and the SPOP-ASCT2 axis, which may explain, at least in part, why some types of cancers (i.e., breast cancer) have a high glutamine consumption while glutamine deficient microenvironment modulates the adaptation mechanisms for tumor survival60,62,63. The gene discussed is SLC1A5; the disease is breast cancer.